Various photos
Gilead Sciences (NASDAQ:GILD) and Danish pharmaceutical company LEO Pharma on Saturday announced an agreement worth up to $1.7 billion to jointly develop and commercialize LEO’s anti-inflammatory drugs.
As part of the deal, Gilead (NASDAQ:GILD) will buy anti-inflammatory drugs from LEO Pharma, which
